# Biomarker–Sleep Correlations in PTSD: Glutamine, Glutathione, Caspase-1, and BDNF Levels Assessed Using the Pittsburgh Sleep Quality Index Addendum

**Authors:** Anna Dorota Grzesińska

PMC · DOI: 10.3390/cimb47100814 · Current Issues in Molecular Biology · 2025-10-02

## TL;DR

This study explores how certain biomarkers relate to sleep issues in PTSD patients, suggesting a link between oxidative stress and trauma-related sleep disturbances.

## Contribution

The study identifies correlations between specific biomarkers and sleep quality in PTSD patients, highlighting differences based on PTSD duration.

## Key findings

- Biomarkers like glutamine and glutathione correlate with sleep disturbances in PTSD patients.
- PTSD patients with shorter diagnosis durations show stronger trauma-related sleep issues.
- Longer PTSD duration is associated with trauma-unrelated anxiety and immune system activation.

## Abstract

Emerging evidence highlights oxidative stress and its biomarkers as potential factors in the onset and maintenance of Post-Traumatic Stress Disorder (PTSD) and co-occurring sleep disturbances. The study concerns the profile of biomarkers including glutamine, glutathione (GSH), caspase-1 and Brain-Derived Neurotrophic Factor (BDNF) levels in three groups (PTSD with a current diagnosis lasting ≤ 5 years, PTSD with a current diagnosis lasting > 5 years, and no PTSD), classified into two age groups. In addition, sleep disturbances were analyzed using the Pittsburgh Sleep Quality Index Addendum (PSQI-A). The study revealed mutual correlations between the examined biomarkers, which may confirm a coordinated antioxidant response. Furthermore, a relationship was observed between biomarkers and PSQI-A; trauma-related domains (e.g., Trauma Nightmares with Terror Episodes) were more pronounced in the case of PTSD ≤ 5 years, while PTSD > 5 years emphasized trauma-unrelated anxiety. The study results suggest that individuals with PTSD exhibit increased sensitivity to trauma, which may manifest through immune system activation and sleep disturbances. Patients with a longer history of PTSD and co-occurring dysfunctions require a personalized approach to trauma treatment and prevention of recurrence.

## Linked entities

- **Proteins:** BDNF (brain derived neurotrophic factor), Caspase1 (caspase-1)
- **Chemicals:** glutamine (PubChem CID 738), glutathione (PubChem CID 124886)
- **Diseases:** Post-Traumatic Stress Disorder (MONDO:0005146), PTSD (MONDO:0005146)

## Full-text entities

- **Genes:** BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}, CASP1 (caspase 1) [NCBI Gene 834] {aka ICE, IL1BC, P45}
- **Diseases:** sleep disturbances (MESH:D012893), anxiety (MESH:D001007), PTSD (MESH:D013313), Trauma (MESH:D014947)
- **Chemicals:** Glutamine (MESH:D005973), GSH (MESH:D005978)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12564656/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12564656/full.md

## References

61 references — full list in the complete paper: https://tomesphere.com/paper/PMC12564656/full.md

---
Source: https://tomesphere.com/paper/PMC12564656